Evidence map›Paper›PMID 38528235›Full record

ArticleJA clinical reports2024

Amino acids to prevent cardiac surgery-associated acute kidney injury: a randomized controlled trial.

Masahiro Kazawa, Daijiro Kabata, Hisako Yoshida, Kimito Minami, Takuma Maeda, Kenji Yoshitani, Hitoshi Matsuda, Ayumi Shintani

Open access · goldAbstract read
In one paragraph

Article in JA clinical reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Masahiro KazawaDepartment of Critical Care Medicine, National Cerebral and Cardiovascular Center, 6-1, Kishibe-Shinmachi, Suita, Osaka, Japan. mas.kazawa@gmail.com.ORCID http://orcid.org/0000-0001-8133-7382
Daijiro KabataDepartment of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Hisako YoshidaDepartment of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Kimito MinamiDepartment of Critical Care Medicine, National Cerebral and Cardiovascular Center, 6-1, Kishibe-Shinmachi, Suita, Osaka, Japan.
Takuma MaedaDepartment of Anesthesiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Kenji YoshitaniDepartment of Anesthesiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Hitoshi MatsudaDepartment of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Osaka, Japan.
Ayumi ShintaniDepartment of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
National Cerebral and Cardiovascular Center · JPOsaka Metropolitan University · JPOsaka City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to examine the preventive effect of amino acids on postoperative acute kidney injury (AKI).

methodsThis was single-center, patient- and assessor-blinded, randomized controlled trial. Patients who underwent aortic surgery with cardiopulmonary bypass were included. The intervention group received 60 g/day of amino acids for up to 3 days. The control group received standard care. The primary outcome was the incidence of AKI. We assessed the effect of amino acids on AKI using a Cox proportional hazards regression model.

resultsSixty-six patients were randomly assigned to the control or intervention group. One patient in the control group withdrew consent after randomization. The incidence of AKI was 10 patients (30.3%) in the intervention group versus 18 patients (56.2%) in the control group (adjusted hazard ratio, 0.44; 95% confidence interval, 0.20-0.95; P = 0.04).

conclusionsThis trial demonstrated a significant reduction in AKI incidence with amino acid supplementation.

trial registrationjRCT, jRCTs051210154. Registered 31 December 2021, https://jrct.niph.go.jp/re/reports/detail/69916.

Indexed as

Acute kidney injuryAmino acidAortic surgery

Identifiers

PMID38528235
PMCPMC10963352
OpenAlexW4393182951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.